Esperion Therapeutics
ESPR
$1.90
Share price
-4.52%
Change (1 day)
43.94%
Change (1 year)
Categories
Esperion Therapeutics (ESPR) - Total debt
Total debt on the balance sheet as of December 2023 : $0.26 B
According to Esperion Therapeutics's latest financial reports the company's total debt is $0.26 B. A company’s total debt is the sum of all current and non-current debts.
Esperion Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | 2% |
| 2022-12-31 | $0.26 B | 0.29% |
| 2021-12-31 | $0.26 B | 40.34% |
| 2020-12-31 | $0.18 B | 11762.32% |
| 2019-12-31 | $1.56 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $1.04 M | -61.74% |
| 2016-12-31 | $2.73 M | -36.37% |
| 2015-12-31 | $4.29 M | -11.85% |
| 2014-12-31 | $4.86 M | |
| 2012-12-31 | $22.76 M | 230.13% |
| 2011-12-31 | $6.89 M | |
| 2002-12-31 | $8.79 M | 38.57% |
| 2001-12-31 | $6.34 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 26,516.55% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $2.70 B | 915.48% | 🇺🇸 USA |
 Ultragenyx RARE | $43.16 M | -83.78% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.10 B | -60.18% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.44 B | 67.21% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 311.67% | 🇺🇸 USA |